Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.

Messaoudene M, Fregni G, Fourmentraux-Neves E, Chanal J, Maubec E, Mazouz-Dorval S, Couturaud B, Girod A, Sastre-Garau X, Albert S, Guédon C, Deschamps L, Mitilian D, Cremer I, Jacquelot N, Rusakiewicz S, Zitvogel L, Avril MF, Caignard A.

Cancer Res. 2014 Jan 1;74(1):81-92. doi: 10.1158/0008-5472.CAN-13-1303. Epub 2013 Nov 13.

PMID:
24225017
[PubMed - indexed for MEDLINE]
2.

Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.

Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G.

J Surg Res. 2013 Aug;183(2):860-8. doi: 10.1016/j.jss.2013.02.025. Epub 2013 Mar 13.

PMID:
23522458
[PubMed - indexed for MEDLINE]
3.

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F.

J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6.

PMID:
19349689
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.

Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, Münz C.

J Immunol. 2004 Feb 1;172(3):1455-62.

PMID:
14734722
[PubMed - indexed for MEDLINE]
Free Article
5.

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, Ratto G, Forte G, Carrega P, Lui G, Conte R, Strowig T, Moretta A, Münz C, Thiel A, Moretta L, Ferlazzo G.

J Immunol. 2007 Apr 15;178(8):4947-55.

PMID:
17404276
[PubMed - indexed for MEDLINE]
Free Article
6.

A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M.

Immunology. 2011 Nov;134(3):326-40. doi: 10.1111/j.1365-2567.2011.03493.x.

PMID:
21978002
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.

Fregni G, Messaoudene M, Fourmentraux-Neves E, Mazouz-Dorval S, Chanal J, Maubec E, Marinho E, Scheer-Senyarich I, Cremer I, Avril MF, Caignard A.

PLoS One. 2013 Oct 18;8(10):e76928. doi: 10.1371/journal.pone.0076928. eCollection 2013.

PMID:
24204708
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, Robin M, Carmagnat M, Loiseau P, Tamouza R, Scieux C, Rabian C, Di Santo JP, Charron D, Janin A, Socié G, Toubert A.

J Immunol. 2008 Aug 1;181(3):2227-37.

PMID:
18641363
[PubMed - indexed for MEDLINE]
Free Article
9.

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.

Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G.

Cancer. 2008 Feb 15;112(4):863-75. doi: 10.1002/cncr.23239.

PMID:
18203207
[PubMed - indexed for MEDLINE]
Free Article
10.

Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties.

Boysen P, Gunnes G, Pende D, Valheim M, Storset AK.

Dev Comp Immunol. 2008;32(7):773-83. doi: 10.1016/j.dci.2007.11.006. Epub 2007 Dec 18.

PMID:
18177938
[PubMed - indexed for MEDLINE]
11.

CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.

Carrega P, Bonaccorsi I, Di Carlo E, Morandi B, Paul P, Rizzello V, Cipollone G, Navarra G, Mingari MC, Moretta L, Ferlazzo G.

J Immunol. 2014 Apr 15;192(8):3805-15. doi: 10.4049/jimmunol.1301889. Epub 2014 Mar 19.

PMID:
24646734
[PubMed - indexed for MEDLINE]
12.

CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP.

Blood. 2010 Jun 3;115(22):4439-46. doi: 10.1182/blood-2010-01-265595. Epub 2010 Mar 25.

PMID:
20339088
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.

Spanholtz J, Tordoir M, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte TM, Dolstra H.

PLoS One. 2010 Feb 15;5(2):e9221. doi: 10.1371/journal.pone.0009221.

PMID:
20169160
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[The expression of chemokine receptors in CD56(bright) CD16- natural killer cells and the mechanism of their recruitment in decidua].

Wu X, Li DJ, Yuan MM, Zhu Y, Wang MY.

Zhonghua Yi Xue Za Zhi. 2004 Jun 17;84(12):1018-23. Chinese.

PMID:
15312539
[PubMed - indexed for MEDLINE]
15.

In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.

Konjević G, Mirjačić Martinović K, Vuletić A, Babović N.

Melanoma Res. 2010 Dec;20(6):459-67. doi: 10.1097/CMR.0b013e32833e3286.

PMID:
20938360
[PubMed - indexed for MEDLINE]
16.

IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

Brehm C, Huenecke S, Quaiser A, Esser R, Bremm M, Kloess S, Soerensen J, Kreyenberg H, Seidl C, Becker PS, Mühl H, Klingebiel T, Bader P, Passweg JR, Schwabe D, Koehl U.

PLoS One. 2011;6(11):e27351. doi: 10.1371/journal.pone.0027351. Epub 2011 Nov 9.

PMID:
22096557
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.

Frankel TL, Burns W, Riley J, Morgan RA, Davis JL, Hanada K, Quezado M, Rosenberg SA, Royal RE.

Cancer Immunol Immunother. 2010 Dec;59(12):1757-69. doi: 10.1007/s00262-010-0897-y. Epub 2010 Aug 24.

PMID:
20734041
[PubMed - indexed for MEDLINE]
18.

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.

Konjević G, Mirjacić Martinović K, Vuletić A, Jović V, Jurisić V, Babović N, Spuzić I.

Clin Exp Metastasis. 2007;24(1):1-11. Epub 2007 Feb 13.

PMID:
17295095
[PubMed - indexed for MEDLINE]
19.

Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.

Anichini A, Scarito A, Molla A, Parmiani G, Mortarini R.

J Immunol. 2003 Aug 15;171(4):2134-41.

PMID:
12902520
[PubMed - indexed for MEDLINE]
Free Article
20.

Role of chemokines in the biology of natural killer cells.

Maghazachi AA.

Curr Top Microbiol Immunol. 2010;341:37-58. doi: 10.1007/82_2010_20. Review.

PMID:
20369317
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk